Keiji Hasumi
- Biotechnology top 0.5%
- Microbial Metabolism and Applications 12
- Biochemistry top 1%
- Eicosanoids and Hypertension Pharmacology 15
- Pharmacology top 1%
- Cancer Research top 5%
- Protease and Inhibitor Mechanisms 37
- Pharmacology top 2%
-
- Acute Ischemic Stroke Management 13
-
- Plant biochemistry and biosynthesis 12
- Signaling Pathways in Disease 12
-
- Cholesterol and Lipid Metabolism 11
-
- Peptidase Inhibition and Analysis 11
- Co-authors
- Akira EndoKaoru SakaiChikara ShinoharaEriko SuzukiKeita ShibataTerumasa HashimotoKazuo HondaWeimin Hu
- Partner nations
- JapanUnited StatesIreland
In The Last Decade
Keiji Hasumi
150 papers receiving 2.9k citations
Peers
Comparison fields: 5 of 120
- Biotechnology 519
- Biochemistry 378
- Pharmacology 772
- Cancer Research 431
- Pharmacology 190
Countries citing papers authored by Keiji Hasumi
This map shows the geographic impact of Keiji Hasumi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Keiji Hasumi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Keiji Hasumi more than expected).
Fields of papers citing papers by Keiji Hasumi
This network shows the impact of papers produced by Keiji Hasumi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Keiji Hasumi. The network helps show where Keiji Hasumi may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Keiji Hasumi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 1 | |
| 3 | 2024 | 0 | |
| 4 | 2024 | 1 | |
| 5 | 2023 | 8 | |
| 6 | 2018 | 15 | |
| 7 | 2018 | 1 | |
| 8 | 2018 | 7 | |
| 9 | 2016 | 8 | |
| 10 | 2016 | 10 | |
| 11 | 2016 | 5 | |
| 12 | 2014 | 26 | |
| 13 | 2010 | 56 | |
| 14 | 2003 | 35 | |
| 15 | 1997 | 11 | |
| 16 | 1995 | 6 | |
| 17 | 1994 | 29 | |
| 18 | 1993 | 47 | |
| 19 | 1992 | 40 | |
| 20 | 1989 | 30 |
About Keiji Hasumi
Keiji Hasumi is a scholar working on Biochemistry, Cancer Research and Biotechnology, having authored 153 papers that have together received 3.0k indexed citations. Recurring topics across this work include Protease and Inhibitor Mechanisms (37 papers), Eicosanoids and Hypertension Pharmacology (15 papers), Acute Ischemic Stroke Management (13 papers), Microbial Metabolism and Applications (12 papers), Plant biochemistry and biosynthesis (12 papers), Signaling Pathways in Disease (12 papers), Cholesterol and Lipid Metabolism (11 papers) and Peptidase Inhibition and Analysis (11 papers). The work is most often cited by research in Biotechnology (519 citations), Biochemistry (378 citations) and Pharmacology (772 citations). Keiji Hasumi has collaborated with scholars based in Japan, United States and Ireland. Frequent co-authors include Akira Endo, Kaoru Sakai, Chikara Shinohara, Akira Endo, Eriko Suzuki, Keita Shibata, Terumasa Hashimoto, Kazuo Honda, Weimin Hu and Koji Nobe. Their work appears in journals such as Journal of Biological Chemistry, Stroke and Journal of Virology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.